EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) STATUS IN DIFFERENT STAGES OF RESECTED NON-SMALL CELL LUNG CANCER (NSCLC): IMPLICATIONS FOR TREATMENT WITH EGFR-TARGETED MONOCLONAL ANTIBODIES

Abstract

Abstract is not available.

    Similar works